ABRAHAM N. OLER - 18 Nov 2021 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)

Role: SVP Corp Dev & Gen Counsel
Signature: /s/ Mark Guerin as attorney-in-fact
Issuer symbol: TRAW
Transactions as of: 18 Nov 2021
Net transactions value: +$15,000
Form type: 4
Filing time: 19 Nov 2021, 07:45:01 UTC
Previous filing: 29 Sep 2021
Next filing: 23 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONTX	Common Stock	Exercise of in-the-money or at-the-money derivative security	$15,000	+5,000	+40%	$3.00	17,514	18 Nov 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ONTX	Warrant (right to purchase)	Exercise of in-the-money or at-the-money derivative security	$0	-5,000	-100%	$0.000000^*	0	18 Nov 2021	Common Stock	5,000	$3.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 9,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee.
F2	The warrants were acquired in the November 2019 public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant.